IL-4-dependent induction of Bcl-2 and Bcl-XL in activated T lymphocytes through a Stat6-and PI 3-kinase-independent pathway

被引:31
|
作者
Aronica, MA
Goenka, S
Boothby, M [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Sch Med, Dept Microbiol & Immunol,Med Ctr N AA4214B, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Sch Med, Dept Med,Allergy Pulm & Crit Care Med Div, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Sch Med, Dept Med,Rheumatol Div, Nashville, TN 37232 USA
关键词
D O I
10.1006/cyto.1999.0603
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Both B and T lymphocytes require ongoing signals to maintain their viability. The pleiotropic cytokine interleukin (IL-) 4 plays an important role in the maintenance of activated T cells, perhaps reflecting induction of the anti-apoptotic genes Bcl-2 and Bcl-X-L. However, it is not known which of the signalling pathways known to link the IL-4 receptor with transcription regulation are required, or if the levels of Bcl-2/X induction under such physiologic conditions are sufficient to account for the anti-apoptotic effects of IL-4, We report here that although blockade of pathways (PI 3-kinase and pp70 S6 kinase) recruited by the IRS-1/2 adaptor proteins inhibited the anti-apoptotic function of IL-4, Bcl-2PX induction were normal. These findings were recapitulated in primary and culture-adapted T cells whose Stat6 signalling pathway also was defective. These results demonstrate that both the Stat6 and PI 3-kinase pathways can be dispensable for Bcl-2/X induction by IL-4, thus suggesting the involvement of an additional signal transduction pathway. Moreover, the preservation of Bcl-2/X induction despite inhibition of the anti-apoptotic function of IL-4 indicates that this cytokine activates additional protective mechanisms. (C) 2000 Academic Press.
引用
收藏
页码:578 / 587
页数:10
相关论文
共 50 条
  • [41] MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies (vol 6, e1593 , 2015)
    Choudhary, G. S.
    Al-harbi, S.
    Mazumder, S.
    Hill, B. T.
    Smith, M. R.
    Bodo, J.
    Hsi, E. D.
    Almasan, A.
    CELL DEATH & DISEASE, 2024, 15 (07):
  • [43] Costimulation of resting B lymphocytes alters the IL-4-activated IRS2 signaling pathway in a STAT6 independent manner: implications for cell survival and proliferation
    Jose ZAMORANO
    Ann E KELLY
    Jonathan AUSTRIAN
    Helen Y WANG
    Achsah D KEEGAN
    Cell Research, 2001, 11 : 44 - 54
  • [44] Costimulation of resting B lymphocytes alters the IL-4-activated IRS2 signaling pathway in a STAT6 independent manner: implications for cell survival and proliferation
    Zamorano, J
    Kelly, AE
    Austrian, J
    Wang, HY
    Keegan, AD
    CELL RESEARCH, 2001, 11 (01) : 44 - 54
  • [45] Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members
    Limaye, V
    Li, XC
    Hahn, C
    Xia, P
    Berndt, MC
    Vadas, MA
    Gamble, JR
    BLOOD, 2005, 105 (08) : 3169 - 3177
  • [46] IL-4 acts as a potent stimulator of IFN-γ expression in CD8+T cells through STAT6-dependent and independent induction of Eomesodermin and T-bet
    Oliver, Jennifer A.
    Stolberg, Valerie R.
    Chensue, Stephen W.
    King, Philip D.
    CYTOKINE, 2012, 57 (01) : 191 - 199
  • [47] Selective induction of apoptosis by the pyrrolo-1,5-benzoxazepine 7-[{dimethylcarbamoyl}oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in leukemia cells occurs via the c-jun NH2-terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-XL
    Mc Gee, MM
    Greene, LM
    Ledwidge, S
    Campiani, G
    Nacci, V
    Lawler, M
    Williams, DC
    Zisterer, DM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (03): : 1084 - 1095
  • [48] Phosphatidylinositol 3′-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors
    Minshall, C
    Arkins, S
    Dantzer, R
    Freund, GG
    Kelley, KW
    JOURNAL OF IMMUNOLOGY, 1999, 162 (08): : 4542 - 4549
  • [49] Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell-mediated Tumor Eradication
    Zhong, Xiao-Song
    Matsushita, Maiko
    Plotkin, Jason
    Riviere, Isabelle
    Sadelain, Michel
    MOLECULAR THERAPY, 2010, 18 (02) : 413 - 420
  • [50] Response differences between human CD4+and CD8+T-lymphocytes during CD3/CD28 costimulation:: Importance of the NF-κB cascade in regulating Bcl-xL and IL-2 promoter activation.
    Laux, I
    Khoshnan, A
    Bae, D
    Nel, A
    FASEB JOURNAL, 2001, 15 (05): : A1043 - A1043